Drug Type siRNA |
Synonyms HT 101, HT-101, HT101 |
Target |
Mechanism HBV RNA inhibitors(HBV RNA inhibitors), RNA interference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B, Chronic | Phase 1 | CN | 21 Nov 2022 | |
Hepatitis D | Phase 1 | CN | - |